217 related articles for article (PubMed ID: 10866348)
1. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
Friedman HS
Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide in malignant gliomas.
Yung WK
Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide for recurrent high-grade glioma.
Macdonald DR
Semin Oncol; 2001 Aug; 28(4 Suppl 13):3-12. PubMed ID: 11550133
[TBL] [Abstract][Full Text] [Related]
5. Treatment of neoplastic meningitis with intrathecal temozolomide.
Sampson JH; Archer GE; Villavicencio AT; McLendon RE; Friedman AH; Bishop WR; Bigner DD; Friedman HS
Clin Cancer Res; 1999 May; 5(5):1183-8. PubMed ID: 10353755
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N; Stupp R
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
[TBL] [Abstract][Full Text] [Related]
8. [Prescription guidebook for temozolomide usage in brain tumors].
Tilleul P; Brignone M; Hassani Y; Taillandier L; Taillibert S; Cartalat-Carel S; Borget I; Chinot O
Bull Cancer; 2009 May; 96(5):579-89. PubMed ID: 19467988
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a side population of astrocytoma cells in response to temozolomide.
Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide: a novel oral alkylating agent.
Danson SJ; Middleton MR
Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide: Expanding its role in brain cancer.
Mrugala MM; Adair J; Kiem HP
Drugs Today (Barc); 2010 Nov; 46(11):833-46. PubMed ID: 21225022
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
Heimberger AB; Archer GE; McLendon RE; Hulette C; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2000 Oct; 6(10):4148-53. PubMed ID: 11051269
[TBL] [Abstract][Full Text] [Related]
13. New approaches for temozolomide therapy: use in newly diagnosed glioma.
Stupp R; Newlands E
Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide. A new option for high-grade astrocytomas.
Schwenka J; Ignoffo RJ
Cancer Pract; 2000; 8(6):311-3. PubMed ID: 11898150
[No Abstract] [Full Text] [Related]
15. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
[TBL] [Abstract][Full Text] [Related]
16. Future directions for temozolomide therapy.
Yung WK
Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
[TBL] [Abstract][Full Text] [Related]
17. [Glioma therapy up-date].
de la Fuente BP; Dalmau J; Rosenfeld M
Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
[TBL] [Abstract][Full Text] [Related]
18. Optimal role of temozolomide in the treatment of malignant gliomas.
Stupp R; van den Bent MJ; Hegi ME
Curr Neurol Neurosci Rep; 2005 May; 5(3):198-206. PubMed ID: 15865885
[TBL] [Abstract][Full Text] [Related]
19. Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma.
Zhou Z; Howard TA; Villano JL
Cancer Chemother Pharmacol; 2017 Nov; 80(5):1043-1046. PubMed ID: 28791452
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
